Correlogic Systems, Inc. Product Pipeline Analysis

SUMMARY

Correlogic Systems, Inc. Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a Correlogic Systems, Inc.'s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

• Details of development stage by sector and equipment type.
• Pipeline products grouped by therapy area, development stage and trial phase.
• Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
• Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
• Product updates covering estimated approval dates and estimated launch dates.
• Descriptions of novel technologies relating to pipeline products of the company.
• Patents and patent applications covered for the product.
• News updates on key events relating to the product and its development.

Reasons to buy

• A single source to fulfill competitor information relating to products in development.
• Identify pipeline products that are potential competitor to your product lines.
Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
• Access clinical trial information to map trial results and plan targeted marketing activities.
• Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
• Identification of potential investment opportunities.
• Build up knowledge base for potential distribution and marketing partners.
• Helps avoid patent infringement.
• Timelines from concept to market lets you keep track of market potential build for a new product.
Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

TABLE OF CONTENTS

1 Table of Contents 3
1.1 List Of Tables 6
1.2 List of Figures 7
2 Company Overview 8
2.1 Key Information 8
2.2 Industry Outlook -- In Vitro Diagnostics 8
3 Major Products and Services 9
3.1 Overview 9
4 Competitors 10
5 Key Employees 11
6 Locations And Subsidiaries 12
6.1 Head Office 12
7 Recent Developments 13
7.1 Product News 13
7.1.1 Feb 19, 2008: Quest Diagnostics To Develop Blood Test To Aid In The Detection Of Colorectal Cancer 13
7.1.2 May 15, 2005: A Serum Pattern Predictive of Breast Cancer 13
7.1.3 May 03, 2005: Development of Correlogic's Prostate Cancer Blood Tests to Move Forward through Research Collaboration with the Uniformed Services University of the Health Sciences and the Henry M. Jackson Foundation for the Advancement of Military Medicine 13
7.1.4 Mar 03, 2005: A Serum Proteomic Approach to Gauging the State of Remission in Wegener's Granulomatosis 14
7.1.5 Jun 21, 2004: Correlogic Systems' Ovarian Cancer Blood Test to Advance through North Shore-LIJ Research Institute Research Collaboration 14
7.1.6 Mar 03, 2004: Toxicoproteomics: Serum Proteomic Pattern Diagnostics For Early Detection Of Drug Induced Cardiac Toxicities And Cardioprotection 14
7.1.7 Nov 06, 2002: Correlogic Systems Licenses Ovarian Cancer Diagnostic Test To Quest Diagnostics and LabCorp 14
8 Correlogic Systems, Inc. Pipeline Products 16
8.1 Correlogic Systems, Inc. Product Pipeline Analysis 16
8.1.1 Correlogic Systems, Inc. Pipeline Products By Equipment Type 16
8.1.2 Correlogic Systems, Inc. Pipeline Products By Development Stage 17
8.1.3 Correlogic Systems, Inc. Pipeline Products By Therapy Area 18
8.1.4 Correlogic Systems, Inc. Pipeline Products By Clinical Trials 18
8.1.5 Correlogic Systems, Inc. Pipeline Products By News Summary 19
8.2 OvaCheck 19
8.2.1 Product Description 20
8.2.2 Product Status 20
8.2.3 Product Milestone 20
8.3 MammoCheck 21
8.3.1 Product Description 21
8.3.2 Product Status 21
8.3.3 Product Milestone 21
8.4 ProstaCheck 22
8.4.1 Product Description 22
8.4.2 Product Status 22
8.4.3 Clinical Trials 22
8.4.4 Product Milestone 23
8.5 Blood test(colorectal cancer) 23
8.5.1 Product Description 23
8.5.2 Product Status 24
8.5.3 Product Milestone 24
8.6 Blood test (Wegners disease) 25
8.6.1 Product Description 25
8.6.2 Product Status 25
8.6.3 Product Milestone 25
8.7 Experimental drug toxicity testing 26
8.7.1 Product Description 26
8.7.2 Product Status 26
8.7.3 Product Milestone 26
9 Appendix 28
9.1 Methodology 28
9.1.1 Coverage 28
9.1.2 Secondary Research 29
9.1.3 Primary Research 29
9.1.4 Expert Panel Validation 30
9.2 Contact Us 30
9.3 About Global Markets Direct 30
9.4 Disclaimer 30

1.1 List Of Tables
Table 1: Correlogic Systems, Inc.,Key Facts 8
Table 2: Correlogic Systems, Inc., Key Employees, 11
Table 3: Correlogic Systems, Inc. Pipeline Products by Equipment Type 16
Table 4: Correlogic Systems, Inc. Pipeline Products By Development Stage 17
Table 5: Correlogic Systems, Inc. Pipeline Products By Therapy Area 18
Table 6: Correlogic Systems, Inc. Pipeline Products By Clinical Trials 18
Table 7: Correlogic Systems, Inc. Pipeline Products By News Summaries 19

1.2 List of Figures
Figure 1: Correlogic Systems, Inc. Pipeline Products By Development Stage 17
Figure 2: Correlogic Systems, Inc. Pipeline Products By News Summary 19
Figure 3: Global Markets Direct Methodology 28